Skip to main navigation Skip to search Skip to main content

Efficacy of susceptibility-matched antibiotic treatment of nontyphoidal Salmonella bloodstream infections: a prospective observational study in hospitalized children under 5 in the Democratic of Congo

  • Bieke Tack
  • , Daniel Vita
  • , Jules Mbuyamba
  • , Jose Nketo
  • , Emmanuel Ntangu
  • , Marie-France Phoba
  • , Aimee Luyindula
  • , Gaelle Nkoji
  • , Hornela Vuvu
  • , Anne-Sophie Heroes
  • , Justin Im
  • , Birkneh Tilahun Tadesse
  • , Mohamadou Siribie
  • , Hyonjin Jeon
  • , Florian Marks
  • , Liselotte Hardy
  • , Karel Allegaert
  • , Erika Vlieghe
  • , Jaan Toelen
  • , Jan Jacobs
  • Octavie Lunguya

Research output: Contribution to journalA1: Peer-reviewed journal articlespeer-review

Abstract

Objectives
In sub-Saharan African children aged under 5 years, nontyphoidal Salmonella (NTS) frequently cause fatal bloodstream infections. Antimicrobial resistance and absence of antibiotic treatment efficacy data challenge effective treatment. In this prospective observational study, we provide treatment efficacy data of susceptibility-matched antibiotic regimens from the treatment of NTS bloodstream infections in children in Kisantu district hospital (Democratic Republic of Congo).

Methods
Children (>28 days to <5 years) admitted with severe febrile illness were enrolled after blood culture sampling. Clinical and microbiological data of children with NTS bloodstream infection were collected in-hospital and at 1-month after discharge.

Results
NTS bloodstream infection was diagnosed in 12.7% (239/1867) of enrolled children. Extensive drug-resistance (concurrent ampicillin, cotrimoxazole, chloramphenicol, third-generation cephalosporin and fluoroquinolone nonsusceptibility) occurred in 60% (144/236), i.e. 69% (71/103) in O5-antigen positive Typhimurium, 85% (72/85) in O5-antigen negative Typhimurium but only 2% (1/48) in Enteritidis serovars. Only 64% (146/228) of children received susceptibility-matched antibiotics and overall in-hospital case fatality was 25.1% (60/239). Compared with susceptibility-mismatched antibiotic treatment, susceptibility-matched third-generation cephalosporin treatment on hospital day 0–1 had better 14-day in-hospital survival (hazard ratio at death [HRdeath]: 0.37 [0.16–0.88]). Similarly, susceptibility-matched third-generation cephalosporin, ciprofloxacin or azithromycin treatment on hospital day 2–6 had better 28-day in-hospital survival (HRdeath: 0.21 [0.06–0.68], 0.15 [0.02–1.10] and 0.26 [0.08–0.84], respectively). After ≥5 days of susceptibility-matched antibiotics, NTS persisted in control blood cultures in 15% (13/88).

Conclusions
NTS bloodstream infections were often extensively drug resistant, leading to susceptibility-mismatched antibiotic treatment. When NTS were susceptible, third-generation cephalosporin, ciprofloxacin and azithromycin treatment appeared to be effective.
Original languageEnglish
JournalClinical Microbiology and Infection
Volume32
Issue number4
Pages (from-to)593-602
Number of pages10
ISSN1198-743X
DOIs
Publication statusPublished - Apr-2026

Keywords

  • Antibiotics
  • Bloodstream infection
  • Children under 5
  • Extensive drug resistance
  • Fluoroquinolone nonsusceptibility
  • Multidrug resistance
  • Nontyphoidal Salmonella
  • Third-generation cephalosporin resistance
  • Treatment efficacy
  • Democratic Republic of the Congo/epidemiology
  • Prospective Studies
  • Humans
  • Child, Preschool
  • Infant
  • Male
  • Microbial Sensitivity Tests
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Bacteremia/drug therapy
  • Infant, Newborn
  • Salmonella Infections/drug therapy
  • Salmonella/drug effects
  • Treatment Outcome
  • Hospitalization
  • Anti-Bacterial Agents/therapeutic use

Fingerprint

Dive into the research topics of 'Efficacy of susceptibility-matched antibiotic treatment of nontyphoidal Salmonella bloodstream infections: a prospective observational study in hospitalized children under 5 in the Democratic of Congo'. Together they form a unique fingerprint.

Cite this